1 active not recruiting, 1 recruiting. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Active not recruiting 1 |
Follow BPH (Benign Prostatic Hyperplasia): new trials by email Literature Review of BPH (Benign Prostatic Hyperplasia) trials Research Report on BPH (Benign Prostatic Hyperplasia)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic Hyperplasia raloxifene, Finasteride - BPH (Benign Prostatic Hyperplasia), Lower Urinary Track Symptoms | Phase 2 | Recruiting | Beth Israel Deaconess Medical Center | 242 | 2025-12-03 | 2026-03-23 |
| RT-310 Safety and Feasibility BPH Study RT-310 - BPH (Benign Prostatic Hyperplasia) | Phase 1 / Phase 2 | Active not recruiting | Resurge Therapeutics Inc. | 20 | 2025-03-13 | 2026-10-30 |
Genital Diseases (2) · Genital Diseases, Male (2) · Male Urogenital Diseases (2) · Prostatic Diseases (2) · Urogenital Diseases (2)
Finasteride (1) · Raloxifene Hydrochloride (1)
Beth Israel Deaconess Medical Center (1) · Resurge Therapeutics Inc. (1)
Dominican Republic (1) · United States (1)
Aria Olumi, MD (1)
R01DK142211 (1)